文献速递其他结缔组织病

混合性结缔组织病的临床特征与严重程度分型:日本全国性回顾研究

Clinical characteristics and severity classification in mixed connective tissue disease: a nationwide retrospective study.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该研究基于日本311例临床诊断MCTD患者中严格符合2019年日本厚生劳动省诊断标准的249例,回顾分析临床特征、主要脏器受累、治疗模式及严重程度相关因素。结果显示MCTD临床异质性显著,32.9%存在主要脏器受累(含肺动脉高压12.8%),约28.7%可评估患者归为重症;抗U1-RNP抗体极高值与严重程度分型或表型大类均无关。

要点

  • 严格符合2019日本MHLW标准的MCTD患者中约28.7%可评估者为重症。
  • 32.9%存在主要脏器受累,肺动脉高压占12.8%。
  • 抗U1-RNP抗体极高值与严重程度分型及表型大类无关。

核心结论

  • MCTD临床异质性显著,严重程度分型与抗U1-RNP抗体极高值状态或表型大类无关联。

研究设计与样本

  • 日本全国性回顾性多中心研究,从311例临床诊断患者中纳入249例严格符合2019年日本厚生劳动省诊断标准者。

主要发现

  • 队列93.1%为女性,中位起病年龄40.6岁,雷诺现象和/或手指或手背肿胀见于100%患者。
  • SLE样与SSc样表型重叠最常见(56.0%),32.0%同时具有SLE样、SSc样和IIM样三个表型域表现。
  • 主要脏器受累见于32.9%患者,其中肺动脉高压占12.8%。
  • 约28.7%可评估患者被归为重症;抗U1-RNP抗体极高值与严重程度分型无关(P=0.492),也与表型大类无关。
  • 糖皮质激素和免疫抑制剂分别用于66.7%和56.5%的患者。

关键数值与推荐

  • 严格符合2019年日本厚生劳动省MCTD诊断标准者纳入分析。
  • 抗U1-RNP抗体极高值与严重程度分型的关联P=0.492。

临床怎么用

  • 对MCTD患者应进行严格的心肺筛查,尤其是肺动脉高压评估。
  • 治疗与管理应根据主导临床表型进行个体化调整。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To characterize clinical manifestations, major organ involvement, real-world treatment patterns and factors associated with severity classification in Japanese patients with mixed connective tissue disease (MCTD), aiming to clarify its heterogeneous clinical spectrum. METHODS: This nationwide retrospective multicentre study analyzed clinical data from 249 patients who strictly fulfilled the 2019 Japanese Ministry of Health, Labour and Welfare diagnostic criteria for MCTD, derived from an initial real-world registry of 311 clinically diagnosed patients. Clinical features, autoantibodies and therapeutic regimens were summarized and compared between patients with severe vs nonsevere disease. RESULTS: The cohort was 93.1% female (median onset age 40.6 years). Common findings, specifically Raynaud's phenomenon and/or swelling of the fingers or dorsum of the hands, were present in 100%. Phenotypically, an overlap of systemic lupus erythematosus (SLE)-like and systemic sclerosis (SSc)-like features was most frequent (56.0%), while 32.0% had manifestations across all three phenotypic domains (SLE-, SSc- and IIM-like). Major organ involvement occurred in 32.9% of patients, including pulmonary arterial hypertension in 12.8%. Approximately 28.7% of evaluable patients were classified as severe. Off-scale-high anti-U1-RNP antibody status was not associated with severity classification (P = 0.492) or with broad phenotypic categories. Glucocorticoids and immunosuppressive agents were used in 66.7% and 56.5% of the patients, respectively. CONCLUSIONS: Mixed connective tissue disease exhibits marked clinical heterogeneity. Severity classification was not associated with off-scale-high anti-U1-RNP antibody status or broad phenotypic categories. These findings support rigorous cardiopulmonary screening and management tailored to the dominant clinical phenotype.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Kubo S, Kanda Y, Kameda H, et al. Clinical characteristics and severity classification in mixed connective tissue disease: a nationwide retrospective study. Rheumatology (Oxford). 2026. PMID: 42879733. doi:10.1093/rheumatology/keag577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。